[go: up one dir, main page]

AU2014208310B2 - A Novel Formulation of Diclofenac - Google Patents

A Novel Formulation of Diclofenac

Info

Publication number
AU2014208310B2
AU2014208310B2 AU2014208310A AU2014208310A AU2014208310B2 AU 2014208310 B2 AU2014208310 B2 AU 2014208310B2 AU 2014208310 A AU2014208310 A AU 2014208310A AU 2014208310 A AU2014208310 A AU 2014208310A AU 2014208310 B2 AU2014208310 B2 AU 2014208310B2
Authority
AU
Australia
Prior art keywords
diclofenac
novel formulation
compositions
methods
medicaments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2014208310A
Other versions
AU2014208310C1 (en
AU2014208310A1 (en
Inventor
H. William Bosch
Aaron Dodd
Felix Meiser
Marck Norret
Adrian Russell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Iceutica Pty Ltd
Original Assignee
Iceutica Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=51494549&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2014208310(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from AU2009901748A external-priority patent/AU2009901748A0/en
Priority claimed from PCT/AU2010/000471 external-priority patent/WO2010121327A1/en
Application filed by Iceutica Pty Ltd filed Critical Iceutica Pty Ltd
Priority to AU2014208310A priority Critical patent/AU2014208310C1/en
Publication of AU2014208310A1 publication Critical patent/AU2014208310A1/en
Application granted granted Critical
Publication of AU2014208310B2 publication Critical patent/AU2014208310B2/en
Publication of AU2014208310C1 publication Critical patent/AU2014208310C1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The present invention relates to methods for producing particles of diclofenac using dry milling processes as well as compositions comprising diclofenac, medicaments produced using diclofenac in particulate form and/or compositions, and to methods of treatment of an animal, including man, using a therapeutically effective amount of diclofenac administered by way of said medicaments.
AU2014208310A 2009-04-24 2014-08-05 A Novel Formulation of Diclofenac Active AU2014208310C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2014208310A AU2014208310C1 (en) 2009-04-24 2014-08-05 A Novel Formulation of Diclofenac

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US17229109P 2009-04-24 2009-04-24
AU2009901748 2009-04-24
AU2009901748A AU2009901748A0 (en) 2009-04-24 A Novel Formulation of Diclofenac
US61/172,291 2009-04-24
PCT/AU2010/000471 WO2010121327A1 (en) 2009-04-24 2010-04-23 A novel formulation of diclofenac
AU2010239080A AU2010239080B2 (en) 2009-04-24 2010-04-23 A novel formulation of diclofenac
AU2014208310A AU2014208310C1 (en) 2009-04-24 2014-08-05 A Novel Formulation of Diclofenac

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU2010239080A Division AU2010239080B2 (en) 2009-04-24 2010-04-23 A novel formulation of diclofenac

Publications (3)

Publication Number Publication Date
AU2014208310A1 AU2014208310A1 (en) 2014-09-11
AU2014208310B2 true AU2014208310B2 (en) 2016-07-21
AU2014208310C1 AU2014208310C1 (en) 2020-01-23

Family

ID=51494549

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2014208310A Active AU2014208310C1 (en) 2009-04-24 2014-08-05 A Novel Formulation of Diclofenac

Country Status (1)

Country Link
AU (1) AU2014208310C1 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006069419A1 (en) * 2004-12-31 2006-07-06 Iceutica Pty Ltd Nanoparticle composition and methods for synthesis thereof
WO2007070852A2 (en) * 2005-12-15 2007-06-21 Acusphere, Inc. Processes for making particle-based pharmaceutical formulations for parenteral administration
WO2007070851A2 (en) * 2005-12-15 2007-06-21 Acusphere, Inc. Processes for making particle-based pharmaceutical formulations for pulmonary or nasal administration
WO2008000042A1 (en) * 2006-06-30 2008-01-03 Iceutica Pty Ltd Methods for the preparation of biologically active compounds in nanoparticulate form

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006069419A1 (en) * 2004-12-31 2006-07-06 Iceutica Pty Ltd Nanoparticle composition and methods for synthesis thereof
WO2007070852A2 (en) * 2005-12-15 2007-06-21 Acusphere, Inc. Processes for making particle-based pharmaceutical formulations for parenteral administration
WO2007070851A2 (en) * 2005-12-15 2007-06-21 Acusphere, Inc. Processes for making particle-based pharmaceutical formulations for pulmonary or nasal administration
WO2008000042A1 (en) * 2006-06-30 2008-01-03 Iceutica Pty Ltd Methods for the preparation of biologically active compounds in nanoparticulate form

Also Published As

Publication number Publication date
AU2014208310C1 (en) 2020-01-23
AU2014208310A1 (en) 2014-09-11

Similar Documents

Publication Publication Date Title
PH12015500301B1 (en) A novel formulation of diclofenac
NZ595985A (en) A novel formulation of naproxen
MY159208A (en) A novel formulation of indomethacin
PH12016500746A1 (en) A novel formulation of meloxicam
MX2011011233A (en) A novel formulation of metaxalone.
PH12015501780A1 (en) Production of encapsulated nanoparticles at commercial scale
MY159098A (en) Production of encapsulated nanoparticles at high volume fractions
MX344238B (en) Tetrazole compounds and methods of making and using same.
EP4371560A3 (en) Pharmaceutical composition, pharmaceutical dosage form, process for their preparation, methods for treating and uses thereof
MY179872A (en) Method for the production of commercial nanoparticle and microparticle powders
MX2014000341A (en) Novel trifluoromethyl-oxadiazole derivatives and their use in the treatment of disease.
WO2011127333A3 (en) Compounds for treating disease, for administering, and for pharmaceutical compositions
HK1206597A1 (en) Spirocyclic dihydro-thiazine and dihydro-oxazine bace inhibitors, and compositions and uses thereof
WO2012103282A3 (en) Methods and compositions for treating alzheimer's disease
MX2008013477A (en) Bicyclic tetrahydropyrrole compounds.
AU2014208310B2 (en) A Novel Formulation of Diclofenac
MX2008011017A (en) Sigma receptor compounds.
PH12015501811A1 (en) Production of encapsulated nanoparticles at high volume fractions
NZ710321A (en) Production of encapsulated nanoparticles at high volume fractions
BRPI1015538A2 (en) new formulation of naproxen

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
NC Extension of term for standard patent requested (sect. 70)

Free format text: PRODUCT NAME: ZORVOLEX DICLOFENAC

Filing date: 20161115

ON Decision of a delegate or deputy of the commissioner of patents (result of patent office hearing)

Free format text: (2018) APO 76: DECISION: I ACCEPT THE APPLICATION FOR AN EXTENSION OF TERM. FOR THE PURPOSES OF SECTION 74(2)(A) THIS DECISION CONSTITUTES NOTIFICATION IN WRITING OF THE ACCEPTANCE. THE ACCEPTANCE WILL NOW BE ADVERTISED IN THE OFFICIAL JOURNAL.

Effective date: 20181030

NDA Extension of term for standard patent accepted (sect.70)

Free format text: PRODUCT NAME: ZORVOLEX DICLOFENAC

Filing date: 20161115

NDB Extension of term for standard patent granted (sect.76)

Free format text: PRODUCT NAME: ZORVOLEX DICLOFENAC

Filing date: 20161115

Extension date: 20311115

DA2 Applications for amendment section 104

Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 05 AUG 2019

TH Corrigenda

Free format text: IN VOL 33 , NO 38 , PAGE(S) 5351 UNDER THE HEADING AMENDMENTS - APPLICATION FOR AMENDMENTS UNDER THE NAME ICEUTICA PTY LTD, APPLICATION NO. 2014208310 CORRECT THE DATE OF THE STATEMENTS FILED TO READ 05 SEP 2019 AND 05 AUG 2019

DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENTS FILED 05 AUG 2019 AND 05 SEP 2019

TH Corrigenda

Free format text: IN VOL 33 , NO 15 , PAGE(S) 2236 UNDER THE HEADING EXTENSIONS OF TERM OF STANDARD PATENT, SECTION 70 - EXTENSIONS GRANTED REGISTER RECTIFIED TO REMOVE EXTENSION OF TERM